Molecular Control of Cell Cycle Progression in the Pancreatic β-Cell
- 25 April 2006
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 27 (4) , 356-370
Abstract
Type 1 and type 2 diabetes both result from inadequate production of insulin by the beta-cells of the pancreatic islet. Accordingly, strategies that lead to increased pancreatic beta-cell mass, as well as retained or enhanced function of islets, would be desirable for the treatment of diabetes. Although pancreatic beta-cells have long been viewed as terminally differentiated and irreversibly arrested, evidence now indicates that beta-cells can and do replicate, that this replication can be enhanced by a variety of maneuvers, and that beta-cell replication plays a quantitatively significant role in maintaining pancreatic beta-cell mass and function. Because beta-cells have been viewed as being unable to proliferate, the science of beta-cell replication is undeveloped. In the past several years, however, this has begun to change at a rapid pace, and many laboratories are now focused on elucidating the molecular details of the control of cell cycle in the beta-cell. In this review, we review the molecular details of cell cycle control as they relate to the pancreatic beta-cell. Our hope is that this review can serve as a common basis and also a roadmap for those interested in developing novel strategies for enhancing beta-cell replication and improving insulin production in animal models as well as in human pancreatic beta-cells.Keywords
This publication has 72 references indexed in Scilit:
- A human β-cell line for transplantation therapy to control type 1 diabetesNature Biotechnology, 2005
- P53 and PrognosisNew Insights and Further ComplexityCell, 2005
- Wagging the DogmaCell, 2004
- Gene therapists hopeful as trials resume with childhood diseaseNature, 2004
- Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entryNature, 2003
- Coordinated regulation of life and death by RBNature Reviews Cancer, 2003
- Cancer geneticsAmerican Journal of Medical Genetics, 2002
- Glutamic acid mutagenesis of retinoblastoma protein phosphorylation sites has diverse effects on functionOncogene, 2000
- Transplanted beta cell response to increased metabolic demand. Changes in beta cell replication and mass.Journal of Clinical Investigation, 1994
- Effects of an Rb mutation in the mouseNature, 1992